Archivel Farma is pleased to share the progress achieved through an R&D project focused on the development and production of bacteriophages targeting Staphylococcus aureus and Klebsiella pneumoniae, two clinically relevant…
Archivel Farma announces that it has received the renewal of its GMP certification for manufacturing, confirming compliance with the requirements of the new Annex 1 to produce sterile and freeze-dried…
Archivel Farma is delighted to anounce the outcome of RUTIVAC study in Bladder Cancer. The RUTI® vaccine, developed and produced in-house by Archivel Farma, was tested in a phase I…
We were pleased to welcome Natalya Serbina, Senior Director at TB Alliance, to Archivel as part of our ongoing collaboration within the international Host Directed Therapy in Tuberculosis project. This…
“Yes! We Can End TB: Commit, Invest, Deliver” TB continues to cause immense human suffering and severe health, social, and economic consequences across the world. Every year, 10 million people…
A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine to shorten treatment in #TB patients. #Archivel Farma has designed and set up a phase IIb clinical study called CONSTAN-ARG to…
The Spanish biotech company Archivel Farma has officially begun the clinical trial of its therapeutic vaccine RUTI®, which will be carried out by Clinical Research Network India, a Contract Research…
The clinical trial will be carried out at the Germans Trias i Pujol Hospital in Badalona (Can RUTI), and it will include 300 healthy health professionals in direct contact with…
Innovative Products
Fogars de Tordera, 61
Pol. Ind. Bonavista
08916 Badalona
T. +34 93 497 24 56
archivel@archivelfarma.com